148 related articles for article (PubMed ID: 19401286)
1. Drug-eluting stents for the treatment of coronary artery disease: NICE technology appraisal guidance.
Messori A; Trippoli S
Heart; 2009 May; 95(10):847. PubMed ID: 19401286
[No Abstract] [Full Text] [Related]
2. Commentary on drug-eluting stents: NICE technology appraisal guidance.
Richardson J; Stevens A; Barnett D; Longson C
Heart; 2008 Dec; 94(12):1650-2. PubMed ID: 18768567
[No Abstract] [Full Text] [Related]
3. NICE guidelines for the use of drug-eluting stents: how do we establish worth?
de Belder MA;
Heart; 2008 Dec; 94(12):1646-8. PubMed ID: 18728067
[No Abstract] [Full Text] [Related]
4. Commentary on drug-eluting stents: to use or not to use--that is the question!
Pfisterer ME
Heart; 2008 Dec; 94(12):1648-50. PubMed ID: 18782796
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
[TBL] [Abstract][Full Text] [Related]
6. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevaliers B; DiMario C; Fajadeto J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Berenger M; Boam A; Calle JP; Campo G; Carlier S; de Schepper J; Di Bisceglie G; Dobbels H; Farb A; Ghislain JC; Hellbardt S; ten Hoedt R; Isaia C; de Jong P; Lekehal M; LeNarz L; Mhullain FN; Nagai H; Patteet A; Paunovic D; Potgieter A; Purdy I; Raveau-Landon C; Ternstrom S; Van Wuytswinkel J; Waliszewski M;
EuroIntervention; 2009 Jan; 4(4):427-36. PubMed ID: 19284063
[No Abstract] [Full Text] [Related]
7. Coronary artery restenosis: a paradigm of current treatment approaches.
Kiernan TJ; Kiernan GD; Yan BD
Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
[TBL] [Abstract][Full Text] [Related]
8. NICE, drug-eluting stents and the limits of trial data.
Mohindra R
Heart; 2009 Mar; 95(6):505-6; author reply 506. PubMed ID: 19252009
[No Abstract] [Full Text] [Related]
9. The drug-eluting stent saga.
Windecker S; Jüni P
Circulation; 2009 Feb; 119(5):653-6. PubMed ID: 19204314
[No Abstract] [Full Text] [Related]
10. Drug-eluting stents in animals and patients: where do we stand today?
Drachman DE
Circulation; 2009 Jul; 120(2):101-3. PubMed ID: 19564555
[No Abstract] [Full Text] [Related]
11. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
12. Bifurcation coronary artery disease: current techniques and future directions (part 2).
Rizik DG; Klassen KJ; Hermiller JB
J Invasive Cardiol; 2008 Mar; 20(3):135-41. PubMed ID: 18316830
[No Abstract] [Full Text] [Related]
13. Cardiology patient page. Drug-eluting stents.
Maisel WH; Laskey WK
Circulation; 2007 May; 115(17):e426-7. PubMed ID: 17470700
[No Abstract] [Full Text] [Related]
14. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
15. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents: costs versus clinical benefit.
O'Neill WW; Leon MB
Circulation; 2003 Jun; 107(24):3008-11. PubMed ID: 12821587
[No Abstract] [Full Text] [Related]
17. Drug-eluting stent for long coronary artery disease.
Park SJ; Kim YH
Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
[No Abstract] [Full Text] [Related]
18. Left main coronary artery stenting: crossing the Rubicon.
Alfonso F
J Am Coll Cardiol; 2009 May; 53(19):1769-72. PubMed ID: 19422983
[No Abstract] [Full Text] [Related]
19. Drug-eluting coronary-artery stents.
Stefanini GG; Holmes DR
N Engl J Med; 2013 Jan; 368(3):254-65. PubMed ID: 23323902
[No Abstract] [Full Text] [Related]
20. Managing technological explosion in the medical management of coronary artery disease, Part II. DES economic modeling: budgeting strategies for drug-eluting stent technology.
Chumer K; DeCerce J; Vaul J
J Cardiovasc Manag; 2002; 13(4):16-20. PubMed ID: 12192774
[No Abstract] [Full Text] [Related]
[Next] [New Search]